// App-Quantinova.ai

967 : Overcoming Multidrug Resistance in B Cell Malignancies By Antagonism of Stromal Mediated TGF-β Signalling

Researchers

Presenter

  • Eugene Park

Principal Investigators

  • Jingyu Chen

  • Andrew Moore

  • Michael Leitges

  • Seth E. Frietze

  • Ingo Ringshausen

Medical Centers

  • University of Cambridge, Cambridge, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

  • Memorial University of Newfoundland, St. John's, NF, Canada

  • Vermont Cancer Center, University of Vermont, Burlington, VT, USA,

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Transforming growth factor beta

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved